Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Verve Therapeutics, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Verve Therapeutics, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.